INTERNATIONAL BIOTECHNOLOGY TRUST PLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 193 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,234,972
+50.3%
26,700
+42.0%
1.09%
+66.4%
Q2 2023$2,152,976
-12.1%
18,800
-40.3%
0.66%
+1.2%
Q2 2021$2,450,000
+4.3%
31,5000.0%0.65%
+4.2%
Q1 2021$2,348,000
-56.2%
31,5000.0%0.62%
-57.6%
Q4 2020$5,364,000
+21.2%
31,5000.0%1.46%
+2.6%
Q3 2020$4,424,000
+26.4%
31,500
+46.5%
1.43%
+22.8%
Q2 2020$3,499,000
+27.5%
21,500
-23.5%
1.16%
-7.0%
Q1 2020$2,744,000
-47.0%
28,100
-29.9%
1.25%
-32.9%
Q4 2019$5,173,000
+163.1%
40,100
+53.6%
1.86%
+105.1%
Q3 2019$1,966,000
-50.4%
26,1000.0%0.91%
-38.2%
Q2 2019$3,965,000
+141.3%
26,100
+89.1%
1.47%
+142.2%
Q1 2019$1,643,000
+12.8%
13,800
-18.8%
0.61%
-32.9%
Q4 2018$1,457,000
-56.4%
17,000
-37.0%
0.90%
-43.1%
Q3 2018$3,344,000
-6.3%
27,0000.0%1.59%
+16.0%
Q2 2018$3,568,000
+78.4%
27,0000.0%1.37%
+75.6%
Q1 2018$2,000,000
+33.2%
27,0000.0%0.78%
+47.2%
Q4 2017$1,502,000
-72.6%
27,000
-77.7%
0.53%
-75.2%
Q3 2017$5,489,000
+167.0%
121,000
+98.4%
2.14%
+173.6%
Q2 2017$2,056,000
+256.9%
61,000
+190.5%
0.78%
+201.5%
Q4 2016$576,00021,0000.26%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders